Sun Pharma Q3 Results: Profit Up 16%, Revenue Sees Uptick
Sun Pharmaceutical Industries's earnings before interest, taxes, depreciation and amortisation was reported to be Rs 4,949 crore versus Rs. 4,009 crore, up 23.4%.
Sun Pharmaceutical Industries's earnings before interest, taxes, depreciation and amortisation was reported to be Rs 4,949 crore versus Rs. 4,009 crore, up 23.4%.
What's Your Reaction?
